A venture capital firm with offices in Western Europe is currently making investments out of its newest fund that had an initial close recently. The firm looks to make equity investments into early stage companies up to €4M, with a focus on Seed to Series A investment rounds. The firm is actively reviewing new opportunities, with a focus in Europe. About 5-10% of the investments will be made in the US.
With the newest fund, the firm is looking for technologies leveraging AI, digital therapeutics, and digital health platforms (i.e. data aggregation). The firm will consider medical device or diagnostics applications that have a AI component, but is most interested in investing in digital health. The firm is open to investing in companies in the earliest stages of development, pre-pilot.
The firm is looking for privately held companies with experienced management teams. The firm is very open to working with incomplete management teams to help them fill out any gaps in management. The firm looks to be a strong value adding investor providing companies with its access to its network of other investors and strategic partners as well. The firm prefers to act as a lead or co-lead, especially in companies based in Spain, but will prefer to syndicate in opportunities outside of Europe.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment